NHS England - Midlands and East Branded Medicines - Tranche B
Estimated value
£295.0m
Awarded value
£295.0m
Suppliers
1
Lots
1
Published
09 Apr 2019
Description
NHS Framework for the Midlands and East, Branded Medicines - Tranche B, Offer reference number: CM/PHR/16/5524 Period of framework agreement: CM/PHR/16/5524/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche B - 1 March 2019 to 28 Feb 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5524/02 - NHS Framework for the Midlands and East, Branded Medicines - Tranche B (Cytokine modulators and other monoclonal antibodies) - 1 March 2019 to 29 Feb 2020 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
Scope
- Reference
- tender_190727/761333
- Total value
- £295,035,882 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Mar 2019 to 28 Mar 2021
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 14 Nov 2018, 12:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£295.0m
Award date
17 Jan 2019
Contract start
01 Mar 2019
Contract end
28 Mar 2021